The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The negative regulatory function of the lymphocyte‐activation gene‐3 co‐receptor (CD223) on human T cells
Abstract
Summary: Accumulating evidence indicates that the CD4 homologue lymphocyte activation gene‐3 (LAG‐3) plays a down‐regulatory role on T‐cell responses. However, the role of LAG‐3/major histocompatibility complex (MHC) class II interactions on primary human T‐cell responses, as well as the mechanism by which down‐regulation occurs, are not clear. Here, we show that LAG‐3 colocalized with CD3, CD4 or CD8 in areas of cholesterol‐rich raft aggregation during this primary response, as well as in the clustered raft region formed between T cells and antibody‐coated beads. Addition of a blocking LAG‐3‐specific monoclonal antibody to both CD4 and CD8 primary resting T cells activated under conditions of antigen‐presenting cell‐driven stimulation and low antigen concentrations augments CD69 activation antigen expression, T‐cell expansion and T helper 1 (Th1, but not Th2) cytokine production. Blocking LAG‐3/MHC class II interactions leads to an increase in the number of cells entering division at these low concentrations of antigen and to more rounds of divisions with an accumulation of cells in the S‐phase of the cell cycle. These results indicate that LAG‐3 signalling inhibits early events in primary activation of human CD4 and CD8 T cells and further support a role for LAG‐3 signalling in regulating the expansion of activated effector or memory T cells, either directly or indirectly through Treg suppressor activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CTLA-4: new insights into its biological function and use in tumor immunotherapy
Egen, J. G., Kuhns, M. S., & Allison, J. P. (2002) · Nature Immunology · doi:10.1038/ni0702-611 · Cited by 940
Cutting Edge: Molecular Analysis of the Negative Regulatory Function of Lymphocyte Activation Gene-3
Workman, C. J., Dugger, K. J., & Vignali, D. A. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5392 · Cited by 389
Workman, C. J., Cauley, L. S., Kim, I.-J., Blackman, M. A., Woodland, D. L., & Vignali, D. A. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5450 · Cited by 351
Cited by
Exploring the NK cell platform for cancer immunotherapy
Myers, J. A., & Miller, J. S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0426-7 · Cited by 1,276
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Qin, S., Xu, L., Yi, M., Yu, S., Wu, K., & Luo, S. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1091-2 · Cited by 1,145
LAG 3 (CD 223) as a cancer immunotherapy target
Andrews, L. P., Marciscano, A. E., Drake, C. G., & Vignali, D. A. A. (2017) · Immunological Reviews · doi:10.1111/imr.12519 · Cited by 956
Matsuzaki, J., Gnjatic, S., Mhawech-Fauceglia, P., Beck, A., Miller, A., Tsuji, T., Eppolito, C., Qian, F., Lele, S., Shrikant, P., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003345107 · Cited by 859
Grosso, J. F., Kelleher, C. C., Harris, T. J., Maris, C. H., Hipkiss, E. L., De Marzo, A., Anders, R., Netto, G., Getnet, D., Bruno, T. C., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31184 · Cited by 547
Metadata
- Authors
- Maçon‐Lemaître, L., & Triebel, F.
- Venue
- Immunology
- Publisher
- Wiley
- Published
- 2005-04-05
- Volume
- 115
- Issue
- 2
- Pages
- 170-178
- ISSN
- 0019-2805 (ISSN-L)
- 1365-2567
- OpenAlex
- W1978715924
- Cited by
- 192
- References
- 3
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The negative regulatory function of the lymphocyte‐activation gene‐3 co‐receptor (CD223) on human T cells. https://app.cochat.ai/papers/10.1111/j.1365-2567.2005.02145.x
- The paper
- Maçon‐Lemaître, L., & Triebel, F. (2005). The negative regulatory function of the lymphocyte‐activation gene‐3 co‐receptor (CD223) on human T cells. Immunology. https://doi.org/10.1111/j.1365-2567.2005.02145.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.